Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Clinical Nutrition ESPEN
|
April 10, 2026
Quantifying the Lifetime Economic Impact of Pediatric Oral Nutritional Supplements
Kyi-Sin Than, Khounish Sharma, Kirk W Kerr, et al.
Journal of Medical Economics
|
January 10, 2026
Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria: implications for decision-making
Kyi-Sin Than, Jason Shafrin, Sanjana Muthukrishnan, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
October 31, 2023
Use of Conditionally Essential Amino Acids and the Economic Burden of Postoperative Complications After Fracture Fixation: Results from a Cost Utility Analysis
Jason Shafrin, Kyi-Sin Than, Anmol Kanotra, et al.
Health Affairs Scholar
|
March 24, 2025
Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers
Sean R Tunis, Jason Shafrin, Kyi-Sin Than, et al.
NPJ Genomic Medicine
|
November 23, 2021
The diagnostic trajectory of infants and children with clinical features of genetic disease
Brock E Schroeder, Nina Gonzaludo, Katie Everson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 23, 2025
A Generalized Risk Adjusted Cost Effectiveness (GRACE) Economic Model for Measuring the Value of Interventions that Delay Mobility Impairment Across Neurological Conditions
Jason Shafrin, Jaehong Kim, Jacob Fajnor, et al.
Forum for Health Economics & Policy
|
July 15, 2025
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology
Jason Shafrin, Kyi-Sin Than, Jacob Fajnor, et al.
Future Oncology (London, England)
|
October 21, 2025
Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US
Erin Mulvey, Jason Shafrin, Kyi-Sin Than, et al.
Breast (Edinburgh, Scotland)
|
July 23, 2022
Progression-free survival and quality of life in metastatic breast cancer: The patient perspective
Shirley Mertz, Christine Benjamin, Charis Girvalaki, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Clinical Nutrition ESPEN
|
April 10, 2026
Quantifying the Lifetime Economic Impact of Pediatric Oral Nutritional Supplements
Kyi-Sin Than, Khounish Sharma, Kirk W Kerr, et al.
Journal of Medical Economics
|
January 10, 2026
Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria: implications for decision-making
Kyi-Sin Than, Jason Shafrin, Sanjana Muthukrishnan, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
October 31, 2023
Use of Conditionally Essential Amino Acids and the Economic Burden of Postoperative Complications After Fracture Fixation: Results from a Cost Utility Analysis
Jason Shafrin, Kyi-Sin Than, Anmol Kanotra, et al.
Health Affairs Scholar
|
March 24, 2025
Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers
Sean R Tunis, Jason Shafrin, Kyi-Sin Than, et al.
NPJ Genomic Medicine
|
November 23, 2021
The diagnostic trajectory of infants and children with clinical features of genetic disease
Brock E Schroeder, Nina Gonzaludo, Katie Everson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 23, 2025
A Generalized Risk Adjusted Cost Effectiveness (GRACE) Economic Model for Measuring the Value of Interventions that Delay Mobility Impairment Across Neurological Conditions
Jason Shafrin, Jaehong Kim, Jacob Fajnor, et al.
Forum for Health Economics & Policy
|
July 15, 2025
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology
Jason Shafrin, Kyi-Sin Than, Jacob Fajnor, et al.
Future Oncology (London, England)
|
October 21, 2025
Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US
Erin Mulvey, Jason Shafrin, Kyi-Sin Than, et al.
Breast (Edinburgh, Scotland)
|
July 23, 2022
Progression-free survival and quality of life in metastatic breast cancer: The patient perspective
Shirley Mertz, Christine Benjamin, Charis Girvalaki, et al.
Page
of 1